BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26247473)

  • 1. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
    Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life.
    Gonçalves TD; Toledo RA; Sekiya T; Matuguma SE; Maluf Filho F; Rocha MS; Siqueira SA; Glezer A; Bronstein MD; Pereira MA; Jureidini R; Bacchella T; Machado MC; Toledo SP; Lourenço DM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E89-96. PubMed ID: 24178797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of type-O blood with neuroendocrine tumors in multiple endocrine neoplasia type 1.
    Weisbrod AB; Nilubol N; Weinstein LS; Simonds WF; Libutti SK; Jensen RT; Marx SJ; Kebebew E
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E109-14. PubMed ID: 23093487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.
    Sakurai A; Imai T; Kikumori T; Horiuchi K; Okamoto T; Uchino S; Kosugi S; Suzuki S; Suyama K; Yamazaki M; Sato A;
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):248-54. PubMed ID: 22690831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
    Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
    Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
    Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.
    Habbe N; Waldmann J; Bartsch DK; Fendrich V; Rothmund M; Langer P
    Surgery; 2008 Nov; 144(5):780-5. PubMed ID: 19081021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN.
    Komminoth P
    Diagn Mol Pathol; 1999 Sep; 8(3):107-12. PubMed ID: 10565680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients.
    de Laat JM; Pieterman CR; van den Broek MF; Twisk JW; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3325-33. PubMed ID: 24915123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual clinical and pathological presentation of a neuroendocrine tumor in a patient with multiple endocrine neoplasia type 1.
    Sakurai A; Murakami A; Sano K; Uchino S; Fukushima Y
    Endocr J; 2009; 56(7):887-95. PubMed ID: 19564705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
    Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
    Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
    D'Adda T; Keller G; Bordi C; Höfler H
    Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.
    Dilley WG; Kalyanaraman S; Verma S; Cobb JP; Laramie JM; Lairmore TC
    Mol Cancer; 2005 Feb; 4(1):9. PubMed ID: 15691381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome.
    Beckers A; Abs R; Reyniers E; De Boulle K; Stevenaert A; Heller FR; Klöppel G; Meurisse M; Willems PJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1498-502. PubMed ID: 7962349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the intrafamilial correlations and heritability of tumor types in MEN1: a Groupe d'étude des Tumeurs Endocrines study.
    Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Le Bras M; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Pasmant E; Chabre O; Castermans E; Ruszniewski P; Bertherat J; Delemer B; Christin-Maitre S; Beckers A; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Schillo F; Bihan H; Archambeaud F; Kerlan V; Bourcigaux N; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
    Eur J Endocrinol; 2015 Dec; 173(6):819-26. PubMed ID: 26392472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.